Caroline Mackie Ogilvie
Papers
1
Total Citations
47
H-Index
1
About
Caroline Mackie Ogilvie is a pioneering figure in clinical cytogenetics and reproductive genetics, best known for her transformative work in advancing array comparative genomic hybridisation (CGH) as a first-line diagnostic tool. Her research focuses on the detection of genome imbalances, prenatal and postnatal genetic diagnosis, and the clinical implementation of high-resolution genomic technologies. Ogilvie’s landmark 2010 study, cited 47 times, provided critical validation for replacing traditional postnatal karyotyping with array CGH, demonstrating a substantial increase in diagnostic yield for patients with suspected genomic disorders. This work helped shift global clinical practice toward more sensitive and comprehensive genomic testing. Beyond this, her contributions have shaped guidelines for prenatal diagnosis and preimplantation genetic testing, improving outcomes for families at risk of inherited conditions. A respected leader in her field, Ogilvie has authored numerous influential papers and served as a key voice in debates on the ethical and practical integration of new technologies into routine care. Her legacy lies in bridging the gap between research innovation and clinical application, ensuring that patients benefit from the most accurate and timely genetic diagnoses possible.
Research Focus
Key Achievements
Top Papers
- 1